Protagenic Therapeutics (PTIX) SEC Filings & 10K Form

$1.25
-0.04 (-3.10%)
(As of 04/22/2024 ET)

Recent Protagenic Therapeutics SEC Filings

DateFilerForm TypeView
04/01/2024
8:41 PM
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
WRIGHT TIMOTHY R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Arrow Alexander K. (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Corvese Brian (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
ARMEN GARO H (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Buell Jennifer (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Barrage Khalil (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Stein Robert Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:50 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:29 PM
ARMISTICE CAPITAL, LLC (Filed by)
Protagenic Therapeutics, Inc.\new (Subject)
Protagenic Therapeutics (Subject)
Form SC 13G/A
12/15/2023
2:50 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
4:18 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:02 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/13/2023
11:48 AM
Arrow Alexander K. (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
2:29 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
1:23 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PTIX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners